Giorgio Trinchieri, MD, NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of his collective contributions to the field of cytokine biology. “The ICIS is honored to present the ICIS-BioLegend William E. Paul Award to Dr. Trinchieri this year for his pioneering contributions to our understanding of the role of cytokines in inflammation, immunity, and cancer. His discovery of interleukin-12 provided the link between cells and cytokines of innate immunity with those of adaptive immunity. His cutting-edge research on the interface of inflammation and immunity will continue to provide knowledge that will translate basic science discoveries to clinical therapeutics.” said Dr. Nancy Reich Marshall, President of the ICIS.
Dr. Trinchieri is currently the Director of the Cancer and Inflammation Program, an NIH Distinguished Investigator and Head of the Cancer Immunobiology Section. Previously Dr. Trinchieri held positions as Professor and Chair of the Immunology Program at the Wistar institute (1990-1999) in Philadelphia, PA and Director of the Schering Plough Laboratory for Immunological Research in Dardilly, France (1999-2004). He is internationally recognized for his seminal contributions to the field of cytokine biology. Collectively, his work has led to the characterization of critical elements involved in the interplay between inflammation/innate resistance and adaptive immunity, and in the definition of central roles of cytokines and interferons in the regulation of hematopoiesis, innate resistance and immunity in infections and cancer.
Dr. Trinchieri’s work truly defined the area of IL-12 biology and has led to multiple patents for use of IL12 in therapeutics.
For more detailed information http://cytokinesociety.org/2018-icis-biolegend-william-e-paul-award/
###
